These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24747769)

  • 1. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
    Muniyan S; Ingersoll MA; Batra SK; Lin MF
    Biochim Biophys Acta; 2014 Aug; 1846(1):88-98. PubMed ID: 24747769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
    Chuang TD; Chen SJ; Lin FF; Veeramani S; Kumar S; Batra SK; Tu Y; Lin MF
    J Biol Chem; 2010 Jul; 285(31):23598-606. PubMed ID: 20498373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
    Veeramani S; Yuan TC; Chen SJ; Lin FF; Petersen JE; Shaheduzzaman S; Srivastava S; MacDonald RG; Lin MF
    Endocr Relat Cancer; 2005 Dec; 12(4):805-22. PubMed ID: 16322323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostatic acid phosphatase: structure, function and regulation.
    Muniyan S; Chaturvedi NK; Dwyer JG; Lagrange CA; Chaney WG; Lin MF
    Int J Mol Sci; 2013 May; 14(5):10438-64. PubMed ID: 23698773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
    Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
    Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
    Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
    J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
    Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
    FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
    Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
    Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
    PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.
    Chou YW; Lin FF; Muniyan S; Lin FC; Chen CS; Wang J; Huang CC; Lin MF
    Cell Biosci; 2015; 5():38. PubMed ID: 26185616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
    Wang SI; Parsons R; Ittmann M
    Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.
    Whang YE; Wu X; Suzuki H; Reiter RE; Tran C; Vessella RL; Said JW; Isaacs WB; Sawyers CL
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5246-50. PubMed ID: 9560261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells.
    Meng TC; Lin MF
    J Biol Chem; 1998 Aug; 273(34):22096-104. PubMed ID: 9705354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
    Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
    Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and functional characterization of a neomorphic PTEN mutation.
    Costa HA; Leitner MG; Sos ML; Mavrantoni A; Rychkova A; Johnson JR; Newton BW; Yee MC; De La Vega FM; Ford JM; Krogan NJ; Shokat KM; Oliver D; Halaszovich CR; Bustamante CD
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13976-81. PubMed ID: 26504226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.